二氢青蒿素抗肿瘤作用及其机制研究进展

被引:13
作者
陆金健 [1 ,2 ,3 ]
黄鸣清 [1 ,2 ,4 ]
陈修平 [1 ,2 ]
王一涛 [1 ,2 ]
机构
[1] 澳门大学中药质量研究国家重点实验室
[2] 澳门大学中华医药研究院
[3] 浙江中医药大学生命科学学院
[4] 福建中医药大学药学院
关键词
二氢青蒿素; 抗肿瘤药; 细胞增殖; 新生血管形成; 肿瘤转移;
D O I
暂无
中图分类号
R96 [药理学];
学科分类号
100602 ; 100706 ;
摘要
二氢青蒿素是青蒿素的重要衍生物,具有显著的抗疟作用。对多种肿瘤动物模型具有一定的肿瘤抑制作用,提示其具有抗肿瘤作用。二氢青蒿素的抗肿瘤作用机制可能与抑制肿瘤细胞增殖包括诱导肿瘤细胞周期阻滞和促进肿瘤细胞凋亡、抑制肿瘤新生血管生成以及抗肿瘤细胞侵袭和转移等有关。细胞内亚铁或亚铁血红素可能是二氢青蒿素抗肿瘤作用的直接靶点。由于二氢青蒿素具有广谱抗肿瘤作用、对正常细胞毒性小及对多药耐药细胞有效等优点,因此有可能被开发为新的抗肿瘤药物。
引用
收藏
页码:397 / 401
页数:5
相关论文
共 17 条
[1]  
Dihydroartemisinin is an inhibitor of ovarian cancer cell growth[J]. Yang JIAO~2,Chun-min GE~3,Qing-hui MENG~3,Jian-ping CAO~2,Jian TONG~2,Sai-jun FAN~(2,3,4)~2 School of Radiology and Public Health,Soochow University,Suzhou 215123,China;~3 Department of Oncology,Lombardi ComprehensiveCancer Center,Georgetown University,Washington DC 20057,USA.Acta Pharmacologica Sinica. 2007(07)
[2]   The JNK inhibitor SP600125 enhances dihydroartemisinin-induced apoptosis by accelerating Bax translocation into mitochondria in human lung adenocarcinoma cells [J].
Lu, Ying-Ying ;
Chen, Tong-Sheng ;
Wang, Xiao-Ping ;
Qu, Jun-Le ;
Chen, Min .
FEBS LETTERS, 2010, 584 (18) :4019-4026
[3]   Suppression of PMA-induced tumor cell invasion by dihydroartemisinin via inhibition of PKCα/Raf/MAPKs and NF-κB/AP-1-dependent mechanisms [J].
Hwang, Yong Pil ;
Yun, Hyo Jeong ;
Kim, Hyung Gyun ;
Han, Eun Hee ;
Lee, Gye Won ;
Jeong, Hye Gwang .
BIOCHEMICAL PHARMACOLOGY, 2010, 79 (12) :1714-1726
[4]   Dihydroartemisinin accelerates c-MYC oncoprotein degradation and induces apoptosis in c-MYC-overexpressing tumor cells [J].
Lu, Jin-Jian ;
Meng, Ling-Hua ;
Shankavaram, Uma T. ;
Zhua, Cai-Hua ;
Tong, Lin-Jiang ;
Chen, Guang ;
Lin, Li-Ping ;
Weinstein, John N. ;
Ding, Jian .
BIOCHEMICAL PHARMACOLOGY, 2010, 80 (01) :22-30
[5]   Dihydroartemisinin inactivates NF-κB and potentiates the anti-tumor effect of gemcitabine on pancreatic cancer both in vitro and in vivo [J].
Wang, Shuang-Jia ;
Gao, Yue ;
Chen, Hua ;
Kong, Rui ;
Jiang, Hong-Chi ;
Pan, Shang-Ha ;
Xue, Dong-Bo ;
Bai, Xue-Wei ;
Sun, Bei .
CANCER LETTERS, 2010, 293 (01) :99-108
[6]   Dihydroartemisinin improves the efficiency of chemotherapeutics in lung carcinomas in vivo and inhibits murine Lewis lung carcinoma cell line growth in vitro [J].
Zhou, Hui-Jun ;
Zhang, Jia-Li ;
Li, Ao ;
Wang, Zeng ;
Lou, Xiao-E .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (01) :21-29
[7]   Dihydroartemisinin upregulates death receptor 5 expression and cooperates with TRAIL to induce apoptosis in human prostate cancer cells [J].
He, Qin ;
Shi, Jingxue ;
Shen, Xiao-Ling ;
An, Jie ;
Sun, Hong ;
Wang, Lu ;
Hu, Ying-Jie ;
Sun, Qing ;
Fu, Lin-Chun ;
Sheikh, M. Saeed ;
Huang, Ying .
CANCER BIOLOGY & THERAPY, 2010, 9 (10) :819-824
[8]  
Growth inhibitory effects of dihydroartemisinin on pancreatic cancer cells: involvement of cell cycle arrest and inactivation of nuclear factor-κB[J] . Hua Chen,Bei Sun,Shuangjia Wang,Shangha Pan,Yue Gao,Xuewei Bai,Dongbo Xue.Journal of Cancer Research and Clinical Oncology . 2010 (6)
[9]   Dihydroartemisinin inhibits growth of pancreatic cancer cells in vitro and in vivo [J].
Chen, Hua ;
Sun, Bei ;
Pan, Shangha ;
Jiang, Hongchi ;
Sun, Xueying .
ANTI-CANCER DRUGS, 2009, 20 (02) :131-140
[10]   Dihydroartemisinin induces apoptosis in HL-60 leukemia cells dependent of iron and p38 mitogen-activated protein kinase activation but independent of reactive oxygen species [J].
Lu, Jin-Jian ;
Meng, Ling-Hua ;
Cai, Yu-Jun ;
Chen, Qin ;
Tong, Lin-Jiang ;
Lin, Li-Ping ;
Ding, Jian .
CANCER BIOLOGY & THERAPY, 2008, 7 (07) :1017-1023